BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23314920)

  • 1. Plasminogen activator inhibitor-1 in kidney pathology (Review).
    Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 and diabetic nephropathy.
    Lee HB; Ha H
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.
    Maquerlot F; Galiacy S; Malo M; Guignabert C; Lawrence DA; d'Ortho MP; Barlovatz-Meimon G
    Am J Pathol; 2006 Nov; 169(5):1624-32. PubMed ID: 17071586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
    Rerolle JP; Hertig A; Nguyen G; Sraer JD; Rondeau EP
    Kidney Int; 2000 Nov; 58(5):1841-50. PubMed ID: 11044203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
    Sandra D; Radha M; Harishkumar M; Yuichi N; Sayuri O; Masugi M
    Phytomedicine; 2010 Jan; 17(1):42-6. PubMed ID: 19640694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.
    Jänicke F; Pache L; Schmitt M; Ulm K; Thomssen C; Prechtl A; Graeff H
    Cancer Res; 1994 May; 54(10):2527-30. PubMed ID: 8168072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes.
    Botta A; Delteil F; Mettouchi A; Vieira A; Estrach S; Négroni L; Stefani C; Lemichez E; Meneguzzi G; Gagnoux-Palacios L
    J Cell Sci; 2012 Sep; 125(Pt 18):4241-52. PubMed ID: 22641690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal fibrosis: not just PAI-1 in the sky.
    Fogo AB
    J Clin Invest; 2003 Aug; 112(3):326-8. PubMed ID: 12897200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer.
    Lobov S; Ranson M
    Cancer Lett; 2011 Apr; 303(2):118-27. PubMed ID: 21316840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
    Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
    FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology].
    Rerolle JP; Vigneau C; Hertig A; Berrou J; Rondeau E
    Nephrologie; 2001; 22(1):5-13. PubMed ID: 11280040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.